Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 242 of 242 entries
Sorted by: Best Match Show Resources per page
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.

Oncogene

Di Giulio S, Colicchia V, Pastorino F, Pedretti F, Fabretti F, Nicolis di Robilant V, Ramponi V, Scafetta G, Moretti M, Licursi V, Belardinilli F, Peruzzi G, Infante P, Goffredo BM, Coppa A, Canettieri G, Bartolazzi A, Ponzoni M, Giannini G, Petroni M.
PMID: 34508175
Oncogene. 2021 Oct;40(43):6143-6152. doi: 10.1038/s41388-021-02003-0. Epub 2021 Sep 10.

MYCN drives aggressive behavior and refractoriness to chemotherapy, in several tumors. Since MYCN inactivation in clinical settings is not achievable, alternative vulnerabilities of MYCN-driven tumors need to be explored to identify more effective and less toxic therapies. We previously...

Cite
Di Giulio S, Colicchia V, Pastorino F, et al. A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene. 2021;40(43):6143-6152doi: 10.1038/s41388-021-02003-0.
Di Giulio, S., Colicchia, V., Pastorino, F., Pedretti, F., Fabretti, F., Nicolis di Robilant, V., Ramponi, V., Scafetta, G., Moretti, M., Licursi, V., Belardinilli, F., Peruzzi, G., Infante, P., Goffredo, B. M., Coppa, A., Canettieri, G., Bartolazzi, A., Ponzoni, M., Giannini, G., & Petroni, M. (2021). A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene, 40(43), 6143-6152. https://doi.org/10.1038/s41388-021-02003-0
Di Giulio, Stefano, et al. "A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors." Oncogene vol. 40,43 (2021): 6143-6152. doi: https://doi.org/10.1038/s41388-021-02003-0
Di Giulio S, Colicchia V, Pastorino F, Pedretti F, Fabretti F, Nicolis di Robilant V, Ramponi V, Scafetta G, Moretti M, Licursi V, Belardinilli F, Peruzzi G, Infante P, Goffredo BM, Coppa A, Canettieri G, Bartolazzi A, Ponzoni M, Giannini G, Petroni M. A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene. 2021 Oct;40(43):6143-6152. doi: 10.1038/s41388-021-02003-0. Epub 2021 Sep 10. PMID: 34508175; PMCID: PMC8553625.
Copy Download .nbib Format: NLM
Perioperative Outcomes of Holmium Laser Enucleation of the Prostate: A Systematic Review.

Urologia internationalis

Porreca A, Colicchia M, Tafuri A, D'Agostino D, Busetto GM, Crestani A, Odorizzi K, Amigoni N, Rizzetto R, Gozzo A, Gallina S, Bianchi L, Ferro M, Falabella R, Romagnoli D, Antonelli A, Corsi P, Schiavina R.
PMID: 34569529
Urol Int. 2021 Sep 21;1-13. doi: 10.1159/000518560. Epub 2021 Sep 21.

INTRODUCTION: The aim of the study was to systematically review the literature and describe perioperative complications of holmium laser enucleation of the prostate (HoLEP), including the Clavien-Dindo classification of surgical complications.METHODS: All English language publications on HoLEP were evaluated....

Cite
Porreca A, Colicchia M, Tafuri A, et al. Perioperative Outcomes of Holmium Laser Enucleation of the Prostate: A Systematic Review. Urol Int. 2021;1-13doi: 10.1159/000518560.
Porreca, A., Colicchia, M., Tafuri, A., D'Agostino, D., Busetto, G. M., Crestani, A., Odorizzi, K., Amigoni, N., Rizzetto, R., Gozzo, A., Gallina, S., Bianchi, L., Ferro, M., Falabella, R., Romagnoli, D., Antonelli, A., Corsi, P., & Schiavina, R. (2021). Perioperative Outcomes of Holmium Laser Enucleation of the Prostate: A Systematic Review. Urologia internationalis, 1-13. https://doi.org/10.1159/000518560
Porreca, Angelo, et al. "Perioperative Outcomes of Holmium Laser Enucleation of the Prostate: A Systematic Review." Urologia internationalis vol. (2021): 1-13. doi: https://doi.org/10.1159/000518560
Porreca A, Colicchia M, Tafuri A, D'Agostino D, Busetto GM, Crestani A, Odorizzi K, Amigoni N, Rizzetto R, Gozzo A, Gallina S, Bianchi L, Ferro M, Falabella R, Romagnoli D, Antonelli A, Corsi P, Schiavina R. Perioperative Outcomes of Holmium Laser Enucleation of the Prostate: A Systematic Review. Urol Int. 2021 Sep 21;1-13. doi: 10.1159/000518560. Epub 2021 Sep 21. PMID: 34569529.
Copy Download .nbib Format: NLM
Showing 241 to 242 of 242 entries